THE COEXPRESSION OF THE preS1(1—42) AND THE CORE (1—144) ANTIGEN OF HBV IN E.coli

Objective:To sutdy the therapeutic T cell vaccine for the treatment of chronic hepatitis B by improving the cellular immunization of HBsAg vaccine with the coexpression of the preS1(1-42)and the Core(1-144)antigen of HBV in E.coli.Methods:The genes of HBcAg(1-144) and preS1(1-42)were amplified and f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese medical sciences journal 2002, Vol.17 (2), p.68-72
1. Verfasser: 赵阳青 詹美云
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective:To sutdy the therapeutic T cell vaccine for the treatment of chronic hepatitis B by improving the cellular immunization of HBsAg vaccine with the coexpression of the preS1(1-42)and the Core(1-144)antigen of HBV in E.coli.Methods:The genes of HBcAg(1-144) and preS1(1-42)were amplified and fused by PCR.This fused gene was inserted in the prokaryotic expression vector pET-11d and expressed in E.coli.Results:It was showed by SDS-PAGE that the protein moloecular weight of the coexpression product was about 20kD,20% of all bacteria protein.The monoclonal antibodies against core and preS1 atibody could react with this fused protein by Western-blot technique respectively.The fused gene was verified by sequencing.Under the immune electron microscopy,this fused protein is typical particles of HBcAg but in an aggregated form.Conclusion:The results might aid for studying T cell immunotherapeutic vaccine for chronic hepatitis B.
ISSN:1001-9294